Jennifer Turner

Summary

Country: Australia

Publications

  1. ncbi WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studies
    Jennifer J Turner
    Department of Anatomical Pathology, St Vincent s Hospital, Level 6, Xavier Building, Darlinghurst, New South Wales, Australia
    Cancer Epidemiol Biomarkers Prev 14:2213-9. 2005
  2. pmc InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions
    Jennifer J Turner
    Department of Histopathology, Douglass Hanly Moir Pathology, and the Australian School of Advanced Medicine, Macquarie University, Sydney, Australia
    Blood 116:e90-8. 2010
  3. ncbi Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma
    Ann Maree Hughes
    School of Public Health, University of Sydney, Sydney, Australia
    Int J Cancer 110:429-34. 2004
  4. pmc Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis
    Claire M Vajdic
    University of New South Wales Cancer Research Center, Prince of Wales Clinical School and National Center in HIV Epidemiology and Clinical Research, University of New South Wales, and Prince of Wales Hospital, Randwick, New South Wales, Australia
    Cancer Res 69:6482-9. 2009
  5. pmc Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling
    To Ha Loi
    Blood Stem Cell and Cancer Research Unit, Department of Haematology, St Vincent s Hospital, Victoria Street, Darlinghurst, Australia
    BMC Med Genomics 4:27. 2011

Collaborators

Detail Information

Publications5

  1. ncbi WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studies
    Jennifer J Turner
    Department of Anatomical Pathology, St Vincent s Hospital, Level 6, Xavier Building, Darlinghurst, New South Wales, Australia
    Cancer Epidemiol Biomarkers Prev 14:2213-9. 2005
    ....
  2. pmc InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions
    Jennifer J Turner
    Department of Histopathology, Douglass Hanly Moir Pathology, and the Australian School of Advanced Medicine, Macquarie University, Sydney, Australia
    Blood 116:e90-8. 2010
    ..We encourage epidemiologists to adopt the updated InterLymph hierarchical classification, which incorporates the most recent WHO entities while demonstrating their relationship to older classifications...
  3. ncbi Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma
    Ann Maree Hughes
    School of Public Health, University of Sydney, Sydney, Australia
    Int J Cancer 110:429-34. 2004
    ..5- to 2-fold increases in risk but with wide confidence intervals. These results provide weak support for the possibility that sun sensitivity or perhaps sun exposure increases risk of NHL...
  4. pmc Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis
    Claire M Vajdic
    University of New South Wales Cancer Research Center, Prince of Wales Clinical School and National Center in HIV Epidemiology and Clinical Research, University of New South Wales, and Prince of Wales Hospital, Randwick, New South Wales, Australia
    Cancer Res 69:6482-9. 2009
    ..This pooled study shows evidence of a modest but consistent reduction in the risk of B-cell NHL associated with atopy...
  5. pmc Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling
    To Ha Loi
    Blood Stem Cell and Cancer Research Unit, Department of Haematology, St Vincent s Hospital, Victoria Street, Darlinghurst, Australia
    BMC Med Genomics 4:27. 2011
    ..In this proof of principle study, gene expression microarray was evaluated as a single platform test in the differential diagnosis of common lymphoma subtypes and reactive lymphadenopathy (RL) in lymph node biopsies...